Copyright Reports & Markets. All rights reserved.

Global Psoriatic Arthritis Therapeutics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Psoriatic Arthritis Therapeutics Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Psoriatic Arthritis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Nonsteroidal Anti-Inflammatory Drug
    • 1.4.3 Disease-Modifying Antirheumatic Drug
    • 1.4.4 Biologic Drug
    • 1.4.5 Enzyme Inhibitor
  • 1.5 Market by Application
    • 1.5.1 Global Psoriatic Arthritis Therapeutics Market Share by Application: 2020 VS 2026
    • 1.5.2 Hospitals
    • 1.5.3 Clinics
    • 1.5.4 Research Labs
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Global Growth Trends

  • 2.1 Global Psoriatic Arthritis Therapeutics Market Perspective (2015-2026)
  • 2.2 Global Psoriatic Arthritis Therapeutics Growth Trends by Regions
    • 2.2.1 Psoriatic Arthritis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Psoriatic Arthritis Therapeutics Historic Market Share by Regions (2015-2020)
    • 2.2.3 Psoriatic Arthritis Therapeutics Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Psoriatic Arthritis Therapeutics Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Psoriatic Arthritis Therapeutics Players (Opinion Leaders)

3 Competition Landscape by Key Players

  • 3.1 Global Top Psoriatic Arthritis Therapeutics Players by Market Size
    • 3.1.1 Global Top Psoriatic Arthritis Therapeutics Players by Revenue (2015-2020)
    • 3.1.2 Global Psoriatic Arthritis Therapeutics Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Psoriatic Arthritis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio
    • 3.2.1 Global Psoriatic Arthritis Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Psoriatic Arthritis Therapeutics Revenue in 2019
  • 3.3 Psoriatic Arthritis Therapeutics Key Players Head office and Area Served
  • 3.4 Key Players Psoriatic Arthritis Therapeutics Product Solution and Service
  • 3.5 Date of Enter into Psoriatic Arthritis Therapeutics Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Psoriatic Arthritis Therapeutics Historic Market Size by Type (2015-2020)
  • 4.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)

  • 5.1 Global Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)
  • 5.2 Global Psoriatic Arthritis Therapeutics Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Psoriatic Arthritis Therapeutics Market Size (2015-2020)
  • 6.2 Psoriatic Arthritis Therapeutics Key Players in North America (2019-2020)
  • 6.3 North America Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
  • 6.4 North America Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

7 Europe

  • 7.1 Europe Psoriatic Arthritis Therapeutics Market Size (2015-2020)
  • 7.2 Psoriatic Arthritis Therapeutics Key Players in Europe (2019-2020)
  • 7.3 Europe Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
  • 7.4 Europe Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

8 China

  • 8.1 China Psoriatic Arthritis Therapeutics Market Size (2015-2020)
  • 8.2 Psoriatic Arthritis Therapeutics Key Players in China (2019-2020)
  • 8.3 China Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
  • 8.4 China Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

9 Japan

  • 9.1 Japan Psoriatic Arthritis Therapeutics Market Size (2015-2020)
  • 9.2 Psoriatic Arthritis Therapeutics Key Players in Japan (2019-2020)
  • 9.3 Japan Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
  • 9.4 Japan Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

10 Southeast Asia

  • 10.1 Southeast Asia Psoriatic Arthritis Therapeutics Market Size (2015-2020)
  • 10.2 Psoriatic Arthritis Therapeutics Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

11 India

  • 11.1 India Psoriatic Arthritis Therapeutics Market Size (2015-2020)
  • 11.2 Psoriatic Arthritis Therapeutics Key Players in India (2019-2020)
  • 11.3 India Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
  • 11.4 India Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

12 Central & South America

  • 12.1 Central & South America Psoriatic Arthritis Therapeutics Market Size (2015-2020)
  • 12.2 Psoriatic Arthritis Therapeutics Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Psoriatic Arthritis Therapeutics Market Size by Type (2015-2020)
  • 12.4 Central & South America Psoriatic Arthritis Therapeutics Market Size by Application (2015-2020)

13 Key Players Profiles

  • 13.1 Pfizer
    • 13.1.1 Pfizer Company Details
    • 13.1.2 Pfizer Business Overview
    • 13.1.3 Pfizer Psoriatic Arthritis Therapeutics Introduction
    • 13.1.4 Pfizer Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020))
    • 13.1.5 Pfizer Recent Development
  • 13.2 Bayer
    • 13.2.1 Bayer Company Details
    • 13.2.2 Bayer Business Overview
    • 13.2.3 Bayer Psoriatic Arthritis Therapeutics Introduction
    • 13.2.4 Bayer Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
    • 13.2.5 Bayer Recent Development
  • 13.3 Novartis
    • 13.3.1 Novartis Company Details
    • 13.3.2 Novartis Business Overview
    • 13.3.3 Novartis Psoriatic Arthritis Therapeutics Introduction
    • 13.3.4 Novartis Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
    • 13.3.5 Novartis Recent Development
  • 13.4 Abbott Laboratories
    • 13.4.1 Abbott Laboratories Company Details
    • 13.4.2 Abbott Laboratories Business Overview
    • 13.4.3 Abbott Laboratories Psoriatic Arthritis Therapeutics Introduction
    • 13.4.4 Abbott Laboratories Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
    • 13.4.5 Abbott Laboratories Recent Development
  • 13.5 Sanofi
    • 13.5.1 Sanofi Company Details
    • 13.5.2 Sanofi Business Overview
    • 13.5.3 Sanofi Psoriatic Arthritis Therapeutics Introduction
    • 13.5.4 Sanofi Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
    • 13.5.5 Sanofi Recent Development
  • 13.6 Bristol-Myers Squibb
    • 13.6.1 Bristol-Myers Squibb Company Details
    • 13.6.2 Bristol-Myers Squibb Business Overview
    • 13.6.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Introduction
    • 13.6.4 Bristol-Myers Squibb Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
    • 13.6.5 Bristol-Myers Squibb Recent Development
  • 13.7 Janssen Biotech
    • 13.7.1 Janssen Biotech Company Details
    • 13.7.2 Janssen Biotech Business Overview
    • 13.7.3 Janssen Biotech Psoriatic Arthritis Therapeutics Introduction
    • 13.7.4 Janssen Biotech Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
    • 13.7.5 Janssen Biotech Recent Development
  • 13.8 Amgen
    • 13.8.1 Amgen Company Details
    • 13.8.2 Amgen Business Overview
    • 13.8.3 Amgen Psoriatic Arthritis Therapeutics Introduction
    • 13.8.4 Amgen Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
    • 13.8.5 Amgen Recent Development
  • 13.9 UCB
    • 13.9.1 UCB Company Details
    • 13.9.2 UCB Business Overview
    • 13.9.3 UCB Psoriatic Arthritis Therapeutics Introduction
    • 13.9.4 UCB Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
    • 13.9.5 UCB Recent Development
  • 13.10 AbbVie
    • 13.10.1 AbbVie Company Details
    • 13.10.2 AbbVie Business Overview
    • 13.10.3 AbbVie Psoriatic Arthritis Therapeutics Introduction
    • 13.10.4 AbbVie Revenue in Psoriatic Arthritis Therapeutics Business (2015-2020)
    • 13.10.5 AbbVie Recent Development

14 Analyst's Viewpoints/Conclusions

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Psoriatic Arthritis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Psoriatic Arthritis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    The key players covered in this study
    Pfizer
    Bayer
    Novartis
    Abbott Laboratories
    Sanofi
    Bristol-Myers Squibb
    Janssen Biotech
    Amgen
    UCB
    AbbVie

    Market segment by Type, the product can be split into
    Nonsteroidal Anti-Inflammatory Drug
    Disease-Modifying Antirheumatic Drug
    Biologic Drug
    Enzyme Inhibitor
    Market segment by Application, split into
    Hospitals
    Clinics
    Research Labs

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    Buy now